Novel Insight of MRI for Lung Cancer and Thoracic Neoplasm
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 11834
Special Issue Editors
Interests: radiation oncology; imaging biomarkers; computed tomography (CT); perfusion CT (PCT); magnetic resonance imaging (MRI)
Interests: magnetic resonance imaging (MRI); diffusion-weighted magnetic resonance imaging (DWI); lung cancer; pulmonary nodule and mass; mediastinal tumor; malignant pleural mesothelioma
Special Issue Information
Dear Colleagues,
Magnetic resonance imaging (MRI) is more useful than CT for the visualization of the heart, the pericardium, and mediastinal vessels. MRI has an advantage specifically for investigating the invasion of the superior vena cava or myocardium, or extension of the tumor into the left atrium via pulmonary veins. Diffusion-weighted magnetic resonance imaging (DWI) can differentiate benign from malignant lesions in many organs, especially in the lung, prostate, breast, and liver. MRI involves no radiation exposure, and no contrast media.
In the next decade, MRI will become more available for the assessment of lung cancer and thoracic neoplasm because CT or FDG-PET/CT has some risk of radiation exposure and MRI is cheaper than PET-CT. DWI possesses great potential for monitoring treatment response in cancer patients shortly after the initiation of radiotherapy. Functional evaluation of DWI will be more useful than that of CT for the response evaluation of chemotherapy and/or radiotherapy of neoplasm. MR functional imaging offers valuable information about tumor tissue, tissue architecture, and cellular biomarkers related to neoplasm.
Pulmonary MRI is radiation-free and makes it possible to replace most CT examinations without suffering any diagnostic loss. MRI examinations will become an alternative to CT and PET/CT and eventually replace them.
This Special Issue will focus on recent developments of specific imaging techniques including MRI for diagnosing and monitoring lung cancer and thoracic neoplasm, taking economical and health care perspectives into consideration. Please submit your valuable research concerning the MRI of lung cancer and thoracic neoplasm in this Special Issue.
Prof. Dr. Munetaka Matoba
Prof. Dr. Katsuo Usuda
Dr. Mariko Doai
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Oncologic imaging
- Cancer imaging
- Imaging of thoracic disease
- Magnetic resonance imaging (MRI)
- Computed tomography (CT)
- Positron emission tomography-computed tomography (PET-CT)
- Diffusion-weighted magnetic resonance imaging (DWI)
- Economic evaluation
- Imaging biomarkers